Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond

Biomaterials. 2024 Apr:306:122478. doi: 10.1016/j.biomaterials.2024.122478. Epub 2024 Jan 20.

Abstract

Platelets play a critical role as circulating cells in the human body and contribute to essential physiological processes such as blood clotting, hemostasis, vascular repair, and thrombus formation. Currently, platelets are extensively employed in the development of innovative biomimetic drug delivery systems, offering significant enhancements in circulation time, biocompatibility, and targeted delivery efficiency compared to conventional drug delivery approaches. Leveraging the unique physiological functions of platelets, these platelet-derived drug delivery systems (DDSs) hold great promise for the treatment of diverse diseases, including cancer, cardiovascular diseases, infectious diseases, wound healing and other diseases. This review primarily focuses on the design and characteristics of existing platelet-derived DDSs, including their preparation and characterization methods. Furthermore, this review comprehensively outlines the applications of these materials across various diseases, offering a holistic understanding of their therapeutic potential. This study aimed to provide a comprehensive overview of the potential value of these materials in clinical treatment, serving as a valuable reference for the advancement of novel platelet-derived DDSs and their broader utilization in the field of disease treatment.

Keywords: Disease treatment; Platelet; Platelet-derived drug delivery systems; Targeted delivery.

Publication types

  • Review

MeSH terms

  • Blood Platelets / physiology
  • Cardiovascular Diseases* / drug therapy
  • Communicable Diseases* / drug therapy
  • Drug Delivery Systems
  • Humans
  • Neoplasms* / drug therapy